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Abstract
Acidosis characterizes the microenvironment ofmost solid tumors and is considered a new hallmark of cancer. It is mainly caused
by both “aerobic” and “anaerobic” glycolysis of differently adapted cancer cells, with the final product lactic acid being
responsible of the extracellular acidification. Many evidences underline the role of extracellular acidosis in tumor progression.
Among the different findings, we demonstrated that acidosis-exposed cancer cells are characterized by an epithelial-to-
mesenchymal transition phenotype with high invasive ability, high resistance to apoptosis, anchorage-independent growth,
and drug therapy. Acidic melanoma cells over-express SOX2, which is crucial for the maintenance of their oxidative metabolism,
and carbonic anhydrase IX, that correlates with poor prognosis of cancer patients. Considering these evidences, we realized that
the profile outlined for acid cancer cells inevitably remind us the stemness profile. Therefore, we wondered whether extracellular
acidosis might induce in cancer cells the acquisition of stem-like properties and contribute to the expansion of the cancer stem cell
sub-population. We found that a chronic adaptation to acidosis stimulates in cancer cells the expression of stem-related markers,
also providing a high in vitro/in vivo clonogenic and trans-differentiating ability. Moreover, we observed that the acidosis-
induced stem-like phenotype of melanoma cells was reversible and related to the EMT induction. These findings help to
characterize a further aspect of stem cell niche, contributing to the sustainment and expansion of cancer stem cell subpopulation.
Thus, the usage of agents controlling tumor extracellular acidosis might acquire great importance in the clinic for the treatment of
aggressive solid tumor.
Key messages
• Extracellular acidosis up-regulates EMT and stem-related markers in melanoma cells
• Acidic medium up-regulates in vitro self-renewal capacity of melanoma cells
• Chronic acidosis adaptation induces trans-differentiation ability in melanoma cells
• Melanoma cells adapted to acidosis show higher tumor-initiating potential than control cells
• Extracellular acidosis promotes a stem-like phenotype in prostate and colorectal carcinoma cells
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Several evidences suggest that cancer stem cells (CSC) are the
ultimate responsible of not only tumor initiation but also met-
astatic disease. CSC represent indeed the only cell population
within the tumor bulk with tumor-initiating and self-renewal
abilities, so that they are likely the unique cancer sub-
population able to generate organ metastases [1].
Among several solid tumors, various reports indicate that
melanomas are particularly enriched in CSC [2] and indeed
considered one of the most aggressive cancers [3]. Melanoma
cells display high phenotypic heterogeneity, expression of de-
velopmental genes, differentiation plasticity, and high tumor-
igenicity supporting the presence of a high number of CSC
[4]. Melanoma cells often display some characteristics of neu-
ral cells [4] and are capable to organize vessel-like structures
mimicking the endothelial cells, undergoing the so-called
vasculogenic mimicry [5]. In specific conditions, melanoma
cells may also acquire fibroblastic or adipogenic differentia-
tion markers [6]. Quintana and colleagues reported that the
incidence of tumorigenic cells in melanoma is greater over
that observed for any other human cancer type [7].
Interestingly, by deeply investigating the tumorigenic and
non-tumorigenic subpopulations, they did not find any signif-
icant phenotypic differences that could account for the diverse
tumorigenic ability of these two populations [7]. They thus
underlined the importance to investigate the role of epigenetic,
genetic, and also environmental factors in inducing tumorige-
nicity. This represents an intriguing starting point to investi-
gate how tumor microenvironment could influence cancer
progression toward malignancy. An embryonic microenviron-
ment has been shown to revert melanoma cells toward a more
benign phenotype [8], while many evidences suggested that
environmental factors such hypoxia and extracellular acidosis
are critical for melanocyte transformation and progression to-
ward malignancy [9–13].
Acidosis of tumor microenvironment is almost an obliga-
tory step associated with the high proliferative rate of cancer
cells exploiting glycolysis not only when oxygen tension re-
duces (anaerobic glycolysis) but even in the presence of suf-
ficient oxygen to sustain oxidative phosphorylation (i.e., near
blood vessels) (aerobic glycolysis or “Warburg effect”), with a
subsequent lactic acid release [14]. Moreover, also the mito-
chondrial respiration, through the spontaneous or enzymatic
CO2 hydration to carbonic acid, contributes to the
extracellular medium acidification [15]. As a direct conse-
quence, almost all solid tumors experience extracellular aci-
dosis (ranging a pH from 6.4 to 7.0) [16], which is also caused
by reduced lymphatic circulation and high interstitial pressure
[17]. Many evidences highlighted the role of extracellular ac-
idosis in the acquisition of tumor aggressive features, so that it
is now recognized as a hallmark of cancer [9, 18, 19]. In the
last years, we contributed to disclose most of the promoting
effects of extracellular acidosis towards tumor malignancy,
and the profile we delineated for the acid-adapted tumor cells
inevitably reminds us the one proposed for CSC. Indeed, ex-
tracellular acidosis stimulates in various types of cancer sev-
eral aspects related to stemness. Besides disclosing that acid-
adapted melanoma cells overexpress well-known stem-related
markers (i.e., SOX2—that sustains the oxidative metabolism
exploited under acidosis [20]—and CAIX [21]—that, pro-
posed as a marker of the pre-metastatic niche, always associ-
ates with resistant phenotype and correlates with very poor
prognosis of tumor patients), we and other research groups
demonstrated that extracellular acidosis induces the
epithelial-to-mesenchymal transition (EMT) program
[22–25], associated with a reduced proliferation rate, a high
metalloprotease-dependent invasive ability [25, 26], and high
apoptotic resistance in tumor cells [25, 27, 28]. Importantly, as
we already reported [25], extracellular acidosis increases mel-
anoma cell metastatic potential by triggering an “incomplete”
or “partial” EMT program, that allows tumor cells to co-
express mesenchymal and epithelial traits at the same time,
and to be prompt to undergo the reverse mesenchymal-to-
epithelial transition (MET) program at convenience during
the metastatic cascade, a distinct sign of the high-plastic tumor
phenotype induced by the acidic microenvironment. Another
important trait of acidic cancer cell defining a high-resistant
tumor phenotype is the anoikis resistance that we found sig-
nificantly increased upon acidic exposure of melanoma cells
[11]. Anoikis resistance is a crucial aspect for aggressive tu-
mor cell subpopulation that, once detached from the primary
mass, must survive into blood stream before their secondary
lodgment. In addition, as a further indication of acidosis-
induced resistant phenotype, acidic BRAF-mutatedmelanoma
cells were found to not respond to targeted and standard che-
motherapy, confirming the great impact of acidic tumor mi-
croenvironment in cancer progression [12].
Thus, we have investigated if an acidic tumor micro-
environment could actually promote the expansion of the
CSC subpopulation by inducing the acquisition of critical
stem-like features in tumor cells. To investigate the influ-
ence of extracellular acidosis on stemness, cancer cells
were chronically exposed to pH 6.7 ± 0.1 (which is the
pH generally found in solid tumors, including melanoma)
and considered “acid-adapted” when they recovered a
proliferation rate similar to control cells maintained at
standard pH [27, 29].
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Methods
Cell cultures
Melanoma cell lines A375M6 [20] and M21 (kindly provided
by Dr. Antony Montgomery, The Scripps Research Institute,
La Jolla, CA), prostate cell line PC3 (purchased from the
American Type Culture Collection, ATCC, Rockville, MD)
and colon cancer cell line HCT116 (a kind gift of Dr. Matteo
Lulli, Department of Clinical and Experimental Biomedical
Sciences “Mario Serio”, University of Florence, Italy) [30],
STR profiled and mycoplasma tested, were cultured in
DMEM 4.5 g/l glucose, 2 mM L-glutamine, and 10% FBS
(Euroclone, Milan Italy). The chronic extracellular acidic con-
dition was mimicked in vitro as previously reported [11].
Briefly, chemical acidified medium was obtained by adding
HCl 1 N in complete culture medium to reach pH 6.7 ± 0.1.
pH value was monitored by using Orion pH meter 520A-1 at
regular intervals during the first hour after the acidification to
check the maintenance of correct pH of the medium. To obtain
chronic acidic cultures, cancer cells were constantly subjected
to a pH 6.7 medium for at least 3 months, until they recovered
a similar growth rate as parent cells maintained at standard pH
7.4 condition. During the long-lasting acidic treatment, no
significant death of cells was found.
MTT assay
Cell viability was assessed using MTT (3-(4,5-dimethyl-
thiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium
reduction assay (Sigma Aldrich, Milan, Italy) as previously
described. Control or acid-adapted cancer cells were plated
into 96-multiwell plates in complete mediumwithout red phe-
nol. After 24, 48, or 72 h the MTT reagent was added to the
medium and plates were incubated at 37 °C. After 3 h, MTT
was removed and the blue MTT–formazan product was solu-
bilized with dimethyl sulfoxide (DMSO) (Sigma Aldrich).
The absorbance of the formazan solution was read at
595 nm using the microplate reader (Bio-Rad, Milan, Italy).
Flow cytometry
Cells were harvested by using Accutase (Euroclone, Milan,
Italy), collected in flow cytometer tubes (2 × 105 cells/tube),
and stained 1 h at 4 °C with anti-CD133 (Affimetrix
eBioscience, part of Thermo Fisher Scientific, Monza, Italy),
anti-CD243 (Affimetrix eBioscience), anti-CD34 (BD
PharMingen, San Diego, CA), anti-CD105 (Ancell, Bayport,
MN), anti-CD73 (BD PharMingen), and anti-CD90 (BD
PharMingen) antibodies. For intracellular antigen detection,
cells were permeabilized for 15 min with 0.25% Tryton X-
100 PBS, and then incubated 1 h at 4 °C with anti-ALDH1A1
(Abcam, Milan, Italy), anti-Nanog (GeneTex, CA, USA),
anti-KLF4 (GeneTex), anti-OCT4 (GeneTex), and anti-
SOX2 (GeneTex) antibodies. Cells were washed in PBS and
incubated 1 h in the dark at 4 °C with secondary antibodies
conjugated with FITC (Merk Millipore, Milan, Italy), Alexa
Fluor 488 (Thermo Fisher Scientific, Monza Italy), PE
(Immunotools, Germany), or APC (Immunotools). Samples
were washed in PBS and analyzed at BD FACSCanto (BD
Biosciences, Milan, Italy). The flow cytometer was calibrated
using cells incubated with secondary antibody only. For each
sample, 1 × 104 events were analyzed.
Tumorsphere formation assay
Control or acid-adapted cancer cells were plated at 150 cells/
cm2 on a low-attachment 100 mm plate in DMEM/F12 sup-
plemented with N2, 5 g/ml insulin, 20 ng/ml FGF-2, and 20
ng/ml EGF (all fromThermo Fisher Scientific) at standard pH.
Cells were allowed to form tumorspheres by 10–15 days. For
serial passaging, 10-day-old tumorspheres were dissociated in
single cells with Accutase (Euroclone), and plated at 150 cells/
cm2 on a low-attachment 100 mm plate for 10 additional days.
In vitro limiting dilution assay
Control or acid-adapted cancer cells were seeded into ultra-
low attachment 96-well plate at different cell doses, with a
maximum of 100 cells per well and a minimum of one cell
per well, and incubated in spheroid-forming conditions for 10
days at 37 °C, at standard pH. Colony formation was assessed
by visual inspection. For each dilution series, we counted
wells that showed sphere formation on day 11. Data were
analyzed and displayed using the Extreme limiting dilution
assay (ELDA) software available at http://bioinf.wehi.edu.
au/software/elda/ [31].
Western blotting analysis
Cells were washed with ice cold PBS containing 1 mM
Na4VO3, and lysed in 100 μl of cell RIPA lysis buffer
(Merk Millipore) containing PMSF (Sigma-Aldrich), sodium
orthovanadate (Sigma-Aldrich), and protease inhibitor cock-
tail (MerkMillipore) as previously described [11]. Aliquots of
supernatants containing equal amounts of protein (50–100μg)
in Bolt LDS Sample Buffer (Thermo Fisher Scientific) were
separated on Bolt® Bis-Tris Plus gels 4–12% precast poly-
acrylamide gels (Thermo Fisher Scientific). Fractionated pro-
teins were transferred from the gel to a PVDF nitrocellulose
membrane using an electroblotting apparatus (Bio-Rad,
Segrate, MI, Italy). Blots were blocked for 1 h, at room tem-
perature, with Odyssey blocking buffer (Dasit Science,
Cornaredo, MI, Italy), and the membrane was probed at 4
°C overnight with primary antibodies diluited in a solution
of 1:1 Odyssey blocking buffer/T-PBS buffer. The primary
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antibodies were mouse anti-Nanog, mouse anti-Oct4, mouse
anti-NFkB p65 (1:500, GeneTex), mouse anti-Vimentin, rab-
bit anti-Zeb1 (1:1000, Santa Cruz Biotechnology, Santa Cruz,
California), rabbit anti-Slug (1:500, Cell signaling
Technology, Danvers, MA, US), rabbit anti-Snai1 (1:500,
Biorbyt, Cambridge, United Kingdom), and mouse anti N-
Cadherin (1:1000, DAKO Agilent, Milan, Italy). The mem-
brane was washed in T-PBS buffer, incubated for 1 h at room
temperature with goat anti-rabbit IgG Alexa Flour 750 anti-
body or with goat anti-mouse IgG Alexa Fluor 680 antibody
(Invitrogen, Monza, Italy), and then visualized by an Odyssey
Infrared Imaging System (LI-COR® Bioscience). Mouse
anti-β-tubulin monoclonal antibody (Sigma, Saint Louis,
MO, USA) was used to assess equal amount of protein loaded
in each lane.
siRNA transfection
For transfections, control siRNA (siCTRL, Thermo Fisher
Scientific) and siRNA for RelA (NF-kB coding gene)
(siRELA, Thermo Fisher Scientific) were diluted in
Optimem medium (Thermo Fisher Scientific) to a final con-
centration of 5 nM and 50 nM for A375M6 and M21, respec-
tively. Transfections were performed using Lipofectamine
3000 reagent (Thermo Fisher Scientific), following the man-
ufacturer's instructions.
Mouse xenograft assays
Six-week-old female CD-1 nude mice (Charles River, Calco,
Lecco, Italy) were injected subcutaneously in lateral flanks
with 102 and 103 A375M6 and M21 melanoma cells
suspended in Matrigel (BD Biosciences)/DMEM (1:1)
(DMEM at standard pH 7.4). Six animals for each cell line
and dilution were used for the experiments, in order to get a
statistically significant data and at the same time to accom-
plish to the 3R principle (Replacement, Reduction, and
Refinement). Animals were monitored daily; subcutaneous
tumor size was measured every 2–3 days by a caliper, and
tumor volumes calculated using the formula V = 4/3π × W/2
× (L/2)2, where W and L are, respectively, tumor width (per-
pendicular tumor diameter) and length (largest tumor diame-
ter). Mice were sacrificed before showing evident signals of
discomfort with an overdose of isoflurane. Statistical analysis
of tumor take was performed using the ELDA software [31].
Experiments with animals were conducted in accordance with
national guidelines and were approved by the ethics commit-
tee of the Animal Welfare Office of the Italian Ministry of
Health (n°401/2015/PR) and conformed to the legal mandates
and Italian guidelines for the care and maintenance of labora-
tory animals.
Adipocyte and osteocyte melanoma cell
differentiation
Sub-confluent melanoma cells seeded in 6-well plate were
treated with pro-adipogenic differentiating medium—
DMEM 1 g/L glucose supplemented with 10% FBS
(Euroclone), 0.5 mM isobutyl methylxanthine, 1 μM dexa-
methasone, 10 μg/ml of insulin, and 70 μM indomethacin
(Sigma Aldrich)—or pro-osteogenic differentiating
medium—DMEM 1 g/L glucose supplemented with 10%
FBS (Euroclone), 10 nM dexamethasone, 100 μg/ml ascorbic
acid, and 10 mM β-glycerophosphate (Sigma Aldrich)—for 3
weeks. Pro-adipogenic and pro-osteogenic differentiating me-
dia were prepared and administered at standard pH. Media
were replaced every other day. Lipid drops of adipogenic-
differentiated melanoma cells were stained by Oil Red O
(Sigma Aldrich): briefly, cells were fixed for 30 min at room
temperature in 4% formaldehyde, then the stock solution
(30 mg Oil Red O powder/10 ml isopropanol) was diluted
3:2 (V:V) in deionized H2O and fixed cells stained for 5
min. Calcium deposits of osteoblast-like-differentiated mela-
noma cells were stained with Alizarin Red (Sigma Aldrich):
briefly, cells were fixed in 70% ethanol for 1 h at 4 °C and
stained for 10 min with 40 mM Alizarin Red solution in de-
ionized H2O at pH 4.2.
To quantify adipocyte and osteoblast-like differentiation of
melanoma cells, qPCR analysis was performed for pro-
adipogenic (LPL, CEBPα and PPARγ) and pro-osteogenic
(ALPL, COL1A1, DMP1, and SOST) differentiation genes.
Quantitative real-time PCR
Total RNA was prepared using Tri Reagent (Sigma-Aldrich),
agarose gel checked for integrity, and reverse transcribed with
iScript cDNA Synthesis Kit (Bio-Rad) according to the man-
ufacturer’s instructions. Selected genes were evaluated by a
real-time qPCR with 7500 Fast Real-Time PCR System
(Applied Biosystems, Monza, Italy). Fold change was deter-
mined by the comparative Ct method calculating the average
of β-actin, β2-microglobulin, TATA-Box Binding Protein
(TBP), and 18s used as reference genes. Amplification was
performed with the PCR setting: 40 cycles of 95 °C for 15 s
and of 60 °C for 60 s using PowerUp SYBR Green Master
Mix (Thermo Fisher Scientific). Primer sequences (IDT,
Tema Ricerca, Bologna, Italy) are listed in Table 1 (β-actin,
β2-microglobulin, TBP, and 18s used as reference genes).
Statistical analysis
The experiments were performed at least five times for a reli-
able application of statistics. All samples used were included
in the statistical analysis. Statistical analysis was performed by
T test, One-way analysis of variance (ANOVA), and Two-
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wayANOVAwith GraphPad Prism 6 software, as specified in
each figure legend. Statistical significances were accepted at p
< 0.05. Values are presented as mean of independent experi-
ments ± SD.
Results
Extracellular acidosis up-regulates EMT and stem-
related markers in melanoma cells
A375M6 and M21 melanoma cells were exposed to pH 6.7
for approximately 3 months and considered “acid-adapted”
when they recovered a proliferation rate similar to control cells
maintained at standard pH (Fig. 1a). Chronic adaptation to
extracellular acidosis, as well as acute exposure [25], induces
a partial EMT program, a feature related to stemness [32], by
maintaining the expression levels of the epithelial marker E-
cadherin and at the same time inducing the acquisition of the
mesenchymal markers N-cadherin and Twist in both A375M6
and M21 cell lines, Snail and Vimentin in only A375M6 cells
(Fig. 1b).
Acid-adapted cells, previously shown to over-express
CAIX [21]—a marker of CSC strongly associated with drug
resistance [33, 34]— also show a higher percentage of
CD133-CAIX co-expressing cells than control (Fig. 1c).
Following these findings, we evaluated, by flow cytometry
analysis, the expression of a panel of stem-related proteins,
observing a significant increase of CD133, CD243,
ALDH1A1, NANOG, and SOX2 for acid-adapted A375M6
and of ALDH1A1, NANOG, KLF4, and OCT4 for acid-
adapted M21 cells compared with control (Fig. 1d).
Extracellular acidosis up-regulates self-renewal ca-
pacity of melanoma cells in vitro
One of the most important property of CSC is the self-
renewal potential, tested in vitro as the ability of melano-
ma cells to form tumorspheres. Acid-adapted A375M6
and M21 ce l l s gave r i se to h igher number of
melanospheres than control, and such ability is further
enhanced along with the serial passages (Fig. 2a). These
results were confirmed using a limiting dilution assay,
where acid-adapted or control cells were evaluated for
sphere formation 10 days later cell plating. By extreme
limiting dilution analysis (ELDA) software analysis [31],
acid-adapted melanoma cells showed a significant in-
crease in tumor-initiating cells (TIC), from 18.7 to
33.7% for A375M6 and from 20 to 33.6% for M21 cells,
suggesting that the low pH is able to expand the self-
renewal population (Fig. 2b).
Reversibility of the acidosis-induced stem-like phe-
notype in melanoma cells
Since CSC have been described as dynamic, able to exhibit
plasticity and to revert their stem cell properties [35], we
grown back acid-adapted melanoma cells in standard pH
medium for 15 days and obtained tumor subpopulations
thereafter referred to as “pH 7.4 restored” (pH 7.4R). By
western blot analysis, we observed that the expression
levels of the stem-related markers Nanog and Oct4, signif-
icantly increased in acid-adapted melanoma cells, did not
vary in pH 7.4R A375M6, while Nanog expression was
significantly reduced in pH 7.4R M21 (Fig. 3a).
Table 1 Primer sequences for

















1435J Mol Med (2020) 98:1431–1446
Interestingly, in both pH 7.4R A375M6 and M21 cells, we
observed a clear reduction of ZEB1 and Snail (Fig. 3a),
two EMT-activators that are also known as stemness medi-
ators [36, 37]. By real-time PCR analysis, we observed a
tendence of stem-related genes, that were found up-
regulated in acid-adapted melanoma cells, to come back
near to the control level, in particular SOX2 and Nanog
in both A375M6 and M21 cells, OCT4 in only M21 cell
line; on the contrary, KFL4 was not only maintained at
high level as acid-adapted cells but was even increased in
Fig. 1 EMT- and stem-related markers of melanoma cells chronically
exposed to extracellular acidosis. a Growth curves of acid-adapted
(Chr.ac.) and control (pH 7.4) A375M6 and M21 cells obtained by
MTT assay. b Real-time PCR of EMT-related markers in acid-adapted
and control A375M6 and M21 cells. c Flow cytometer analysis of CAIX
and CD133 co-expressing cells under standard and acidic conditions. d
Flow cytometer analysis of stem-related markers in A375M6 and M21
cells exposed to extracellular acidosis compared with control. *p < 0.05,
**p < 0.01, ***p < 0.001, Two-way ANOVA Sidak's multiple compar-
isons test for a, b, and d; t test for c
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both pH 7.4R cell lines (Fig. 3b). Moreover, the pH 7.4R
melanoma cells showed a significantly reduced tumorsphere
formation ability (Fig. 3c) and a decreased TIC percentage
(Fig. 3d) compared with acid-adapted melanoma cells,
despite still increased compared with control cells. These
data suggest that the stem-like phenotype of melanoma
cells induced by acidosis is reversible, but 15 days is not
enough to reach a complete phenotype reversion.
Fig. 2 In vitro self-renewal ability ofmelanoma cells chronically exposed
to extracellular acidosis. a Tumorsphere formation assay of A375M6 and
M21 cells under chronic extracellular acidosis (Chr.ac.) and standard
condition (pH 7.4). Representative images (left) and relative quantifica-
tion chart (right) of spheres from passage 1 to 4 (p1–p4). Scale bar: 200
μm. b Limiting dilution sphere assay of acid-adapted and control
A375M6 and M21 cells. ELDA analysis plot (upper) and relative table
reporting the TIC percentage (lower). *p < 0.05, **p < 0.01, ***p <
0.001, Two-way ANOVA, Sidak's multiple comparisons test
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Fig. 3 The acidosis-induced stem-like phenotype is partially reversible
by restoring standard pH condition. a WB analysis of EMT- and stem-
related markers in control (pH 7.4), acid-adapted (Chr.ac.), and pH 7.4
restored (pH 7.4R) A375M6 and M21 cells. b Real-time PCR of stem-
related markers in control, acid-adapted, and pH 7.4 restored A375M6
and M21 cells. Tumorsphere formation (c) and limiting dilution sphere
(d) assays of control, acid-adapted and pH 7.4 restoredA375M6 andM21
cells. *p < 0.05, **p < 0.01, ***p < 0.001; two-way ANOVA, Sidak's
multiple comparisons test for a; one-way ANOVA, Tukey's multiple
comparisons test for b and c
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EMT is required for the acquisition of the acidosis-
induced stem-like phenotype in melanoma cells
Since recent papers revealed the fundamental role of EMT in
stemness induction [32], we wondered if the induction of an
EMT phenotype in acid-adapted melanoma cells was required
for the acquisition of stemness features. The NF-kB transcrip-
tional factor is known to regulate EMT in different type of
cancers [38, 39], and, in addition, we previously reported that
it drives the acidosis-induced EMT in melanoma cells [25].
We thus decided to down-regulate acidosis-induced EMT by
silencing the NF-kB coding gene RelA and observed, bywest-
ern blot analysis, a clear reduction of the EMT markers N-
Cadherin, Zeb1, Vimentin, and Slug (even though its reduc-
tion was not significant), and of the stem-related marker
Nanog (Fig. 4a). The real-time PCR analysis confirmed the
reduction in mRNA expression of the EMT markers N-
Cadherin, Twist, Snail, and Vimentin and of the stem-related
markers SOX2, OCT4, KFL4, and Nanog (Fig. 4b). Finally,
the tumor sphere formation (Fig. 4c) and the in vitro limiting
dilution (Fig. 4d) assays, respectively, showed a reduced
melanosphere formation and a decreased TIC percentage in
both the cell lines tested. These data suggest that the EMT
program is required for the acquisition of a stem-like pheno-
type by acid-adapted melanoma cells.
Melanoma cells adapted to extracellular acidosis
show higher tumor-initiating potential than control
cells
Tumor-initiation ability in vivo was tested by subcutaneously
injecting in CD-1 nude mice a low number of standard and
acid-adapted A375M6 and M21 melanoma cells and allowed
to generate tumor masses. By injecting 102 acid-adapted
A375M6 (Fig. 5a), nodules developed in higher number and
earlier compared with control (5/6 tumors at day 18 vs 2/6
tumors at day 27, respectively), and also increased in tumor
volume (Fig. 3a, left panel). The ELDA analysis indicated that
acid-adapted group contains higher percentage of TIC than
control (0.40% vs 0.15%, respectively) (Fig. 5a, right panel).
By injecting 103 A375M6 cells, no significant differences
were observed between control and acid-adapted group (4/6
tumors at day 20 vs 5/6 tumors at day 22, respectively; data
not shown), suggesting that acid-adapted A375M6 melanoma
cells contain an expanded TIC subpopulation emerging when
using a low number of cancer cells.
Thereafter, injecting 102 control or acid-adapted M21 mel-
anoma cells, a similar and very low incidence was obtained
(1/6 tumors of both groups), although latency (day 50 for acid-
adapted vs day 60 for control group) and tumor volume eval-
uation indicated a more effectiveness of acid-adapted cells
than control (data not shown). Increasing the number of
injected M21 cells up to 103, significant differences between
the two groups have been observed in terms of incidence (4/6
tumors for acid-adapted vs 1/6 tumors for control group), la-
tency (day 28 for acid-adapted vs day 54 for control group),
and tumor volume (Fig. 5b, left panel). The ELDA analysis
(Fig. 5b, right panel) clearly showed that the percentage of
TIC of acid-adapted group is higher than in control one
(0.12% vs 0.03%, respectively).
Chronic acidosis adaptation induces high plasticity
and trans-differentiation ability in melanoma cells
A different way to test in vitro stemness of tumor cells is to
evaluate their ability to trans-differentiate in other cellular
types when subjected to specific differentiating stimuli. To
this aim, standard and acid-adapted melanoma cells were cul-
tured for 3 weeks under pro-adipogenic- or pro-osteogenic-
differentiating media and then evaluated by molecular and
histological techniques. We firstly checked by flow cytometry
their intrinsic predisposition to express the CD105, CD73, and
CD90 mesenchymal stem cell markers, and the CD34 hema-
topoietic stem cell marker was used as negative control, ob-
serving that chronic acidosis increased the expression of
CD105, CD73, and CD90 in A375M6 and CD105 in M21
cells compared with control cells (Fig. 6a). Treating melano-
ma cells for 3 weeks with pro-adipogenic-differentiating me-
dium, we observed a higher trans-differentiation ability of
acid-adapted cells compared with control cells, assessed via
qPCR analysis of the adipogenic markers LPL, CEBPα, and
PPARγ, and via Oil Red O staining of intracytoplasmic lipid
drops (Fig. 6b). In parallel, we observed that the pro-
osteogenic-differentiating medium induces a stronger positiv-
ity for the Alizarin Red staining in acid-adapted melanoma
cells compared with control cells, despite at a molecular level
only ALPL (for A375M6 and M21 cells) and SOST (for M21
cells) genes were significantly increased in acidic-adapted
cells (Fig. 6c). These findings disclose the ability of acid-
adapted A375M6 and M21 melanoma cells to easily trans-
differentiate towards mesoderm-derived lineages upon specif-
ic stimuli.
Extracellular acidosis promotes a stem-like phenotype
in prostate and colorectal carcinoma cells
To verify whether a chronic low pHmight be also able to extend
the stem-cell subpopulation not only in melanoma but also in
other tumor types, we evaluated some aspects of CSC in prostate
and colorectal adenocarcinoma cell lines, PC3 and HCT116,
respectively, chronically exposed to an acidic medium com-
pared with control. First of all, we observed that acid-adapted
prostate and colon cancer cells, compared with control, express
higher protein levels of stem-related markers (Fig. 7a).
Moreover, limiting dilution analysis shows that acid-adapted
PC3 and HCT116 cells display an increased self-renewal
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Fig. 4 EMT down-regulation via RELA silencing in acid-adapted mela-
noma cells reduces the stem-like phenotype. WB (a) and real-time PCR
(b) analysis of EMT- and stem-related markers in siCTRL and siRELA
acid-adapted A375M6 and M21 cells. Tumorsphere formation (c) and
limiting dilution sphere (d) assays of siCTRL and siRELA acid-adapted
A375M6 and M21 cells. *p < 0.05, **p < 0.01, ***p < 0.001; two-way
ANOVA, Sidak's multiple comparisons test for a and b; t test for c
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potential, suggested by the higher sphere frequency and the TIC
percentage obtained by ELDA analysis (Fig. 7b). In line with
these results, acid-adapted PC3 and HCT116 cells also gave rise
to higher number of tumorspheres compared with control (Fig.
7c), highlighting the possibility that acidosis promotion of
stemness is a more general phenomenon that could be extended
to different tumor types.
Discussion
Many types of cancer display subpopulations of CSC,
that share features with physiological stem cells (i.e.,
self-renewal, differentiation, indefinite proliferation abili-
ties) through which they cause tumor progression
[40–42]. CSC are protected and maintained in a well-
Fig. 5 Extracellular acidosis increases in vivo tumor initiation and
growth of melanoma cells. In vivo tumor growth (left) and estimated
tumor-initiation frequency (ELDA software) (right) after subcutaneous
injection in CD-1 mice of either 100 acid-adapted (Chr.ac.) or standard
(pH 7.4) A375M6 cells (a) or 1000 acid-adapted or standard M21 cells
(b). **p < 0.01, ***p < 0.001; two-way ANOVA, Sidak's multiple com-
parisons test (pH 7.4 vs Chr.ac. for each time point)
1441J Mol Med (2020) 98:1431–1446
defined microenvironment providing a permissive niche
able to enforce their survival ability and aggressive
properties [43]. Alongside hypoxia, that plays an impor-
tant role in stemness [44], extracellular acidosis might
Fig. 6 Chronic acidosis adaptation induces high plasticity and trans-
differentiation ability in melanoma cells. a Flow cytometer analysis for
the expression of the mesenchymal markers CD105, CD73, and CD90 in
acid-adapted (Chr.ac.) A375M6 andM21 compared with relative control.
CD34 used as negative control. b Real-time PCR analysis for adipogenic
differentiation markers LPL, CEBPα, and PPARγ (left) and representa-
tive pictures of Oil Red O lipid drop staining (right) in acid-adapted
A375M6 andM21 compared with control cells. cReal-time PCR analysis
for osteogenic differentiation markers ALPL, COL1A1, DMP1, and
SOST (left) and representative pictures of Alizarin Red calcium phos-
phate deposit staining (right) in acid-adapted A375M6 and M21 com-
pared with control cells. Scale bar: 50 μm. *p < 0.05, **p < 0.01, ***p
< 0.001; two-way ANOVA, Sidak's multiple comparisons test
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represent another crucial characteristic of tumor microen-
vironment able to influence stemness of cancer cells.
We collected a wide number of evidences inevitably
linking a possible association between chronic extracellular
acidosis and the promotion of a stem-like phenotype in mela-
noma cells.
Notably, EMT, apoptosis resistance, anoikis, and drug re-
sistance features, we already observed under acidic condi-
tions, have been linked to a tumor profile with successful
metastatic dissemination [6, 45, 46]. Here we demonstrate that
a higher number of acid-adapted melanoma cells co-express
CAIX and CD133 proteins compared with control, a further
indication of acidosis-induced stemness. Indeed, CAIX ex-
pression has been correlated with stem cell niches in normal
tissues [47] and considered a critical mediator of the self-
renewal and invasive potential of cancer cells by regulating
the transcription of EMT- and stemness-related genes [33, 48].
Here we show the induction of the self-renewal and
pluripotency markers Nanog, KLF4, OCT4, and SOX2 and
the over-expression of the CSC markers CD133, CD243, and
ALDH1A1 in melanoma cells exposed to chronic acidosis
compared with control cells. In line with our results, acidosis
has been associated with the increased CSC-marker expres-
sion in prostate cancer [49] and malignant glioma [50, 51],
Fig. 7 Stem-like features of
prostate and colorectal cancer
cells chronically exposed to
extracellular acidosis. a Flow
cytometer analysis for stem-
related markers in PC3 prostate
and HCT116 colorectal cancer
cells exposed to chronic acidosis
(Chr.ac.) compared with control
(pH 7.4). b Limiting dilution
sphere assay of acid-adapted and
control PC3 and HCT116 cells.
ELDA analysis plot (upper panel)
and relative TIC percentage value
(lower panel). c Tumorsphere
formation assay of PC3 and
HCT116 cells under chronic ex-
tracellular acidosis and standard
condition *p < 0.05, **p < 0.01,
***p < 0.001; two-way ANOVA,
Sidak's multiple comparisons test.
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osteosarcoma [52], and the maintenance of stemness in mes-
enchymal cells [53, 54]. Also, OCT-4 expression in murine
fibroblasts increases as pH shifts from 7.4 to 6.5 [55].
We confirmed that extracellular acidosis induces the self-
renewal capability of cancer cells by the in vitro tumorsphere
formation and limiting dilution assays. We found that acid-
adapted cells give a higher number of melanospheres with
bigger size than control cells and preserve their stem-like phe-
notype for at least four passages, whereas control cells gradu-
ally lose their ability to form melanospheres. This effect is not
limited to melanoma, but rather proved in PC3 prostate and
HCT116 colon cancer cells, that indeed also showed high
expression of stem-related proteins.
We also showed that the stem-like phenotype induced in
melanoma cells by acidosis is a reversible phenomenon, as
suggested by the reduced expression of stem-related markers
and by the lower self-renewal capability of acid-adapted cells
grown back for 15 days at standard pH medium, compared
with acid-adapted cells. The phenotype we observed was not
completely reverted at control level, but the phenomenon was
clear enough to confirm that the acidosis-induced stem-like
phenotype is dynamic and subjected to variations depending
on environmental conditions, an evidence that contributes to
define the increased plasticity and aggressiveness of acid-
adapted tumor cells [35].
Several studies have demonstrated the link between EMT
and stemness in a variety of human carcinoma [32, 45], and
recently, EMT with its mediators, such as Zeb1 [36], Snail
[37], Slug [56], and NF-kB [57, 58], has been described as a
key mechanism by which cells are conferred with stem-cell
properties. Here, we demonstrated that the stem-like pheno-
type induced in acid-adapted melanoma cells is EMT-depen-
dent, since by inhibiting the well-known EMT mediator NF-
kB, the stem-like phenotype acquired by acid-adapted mela-
noma cells has clearly been reduced.
CSC are also denominated tumor-initiating cells (TIC) be-
ing responsible for the initiation, recurrence, and metastases of
a tumor. For that, increased in vivo tumorigenicity is one of
the hallmarks of CSC. Interestingly, melanoma TIC popula-
tion has been demonstrated to depend on SOX2 expression
[59], that we found up-regulated under acidic conditions [20].
The in vivo evaluation of the tumor-initiation ability of acid-
adapted melanoma cells compared with control showed that
chronic acidosis induces the earlier development of a higher
number of tumors compared with the standard pH condition,
and the ELDA statistical analysis revealed a higher percentage
of TIC in acid-adapted group than control. Some evidences
showed that increasing the extracellular pH reduces tumor
growth, prevents cancer invasion [26, 60], and restores drug
sensitivity [61]. Recently acidosis has been proposed as po-
tential therapeutic target to eradicate CSC [62].
Another hallmark of CSC is the multi-lineage differentia-
tion plasticity that influences tumor progression and drug
resistance [63]. Based on the origin of melanoma, we thought
that the melanoma CSC should potentially differentiate into
mesenchymal cell types, such as adipocytes and osteoblast-
like cells. By treating melanoma cells with appropriate differ-
entiating media, we observed that acid-adapted melanoma
cells, compared with control, show higher ability to trans-
differentiate in adipocyte and osteoblast-like cells. A recent
study showed that a continuous exposure to low pHe for 21
days of bone marrow stem cells and dental pulp stem cells
impairs the osteogenic differentiation of both cell types [53],
suggesting that extracellular acidosis is crucial for the mainte-
nance of a de-differentiated state.
To conclude, our results provide evidences that acidity
leads to a reprogramming of a very plastic tumor phenotype
toward the expression of stem-related markers, high
clonogenic, and trans-differentiating ability. This could clarify
the reasons why extracellular acidosis is able to promote ag-
gressive traits in cancer, dramatically contributing to tumor
progression and metastatic disease. Thus, acidosis needs to
be considered a new and specific cue of stem cell niche, able
to offer an innovative target for cancer therapy.
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